Category

Global Antibiotic Market - Forecasts From 2019 To 2024

105 pages
Published on : May 2019
Report Code : KSI061612361

Description

The global antibiotic market is projected to grow at a CAGR of 2.89 percent to reach a market size of USD 69.970 billion by 2024.  The global antibiotics market is poised to grow at a sustainable rate in the forecast period due to the prevalence of microbial infections, growing research and development investment, rising healthcare expenditure and growing pharmaceutical industry. North America and Europe are expected to hold a significant market share due to the early adoption of innovations, the highest healthcare spending of the United States and the presence of major industry players in these regions. However, rising concerns of antibiotic resistance may hinder the market growth during the forecast period.

DRIVERS

Prevalence of microbial infections

Growing pharmaceutical industry

Increasing health expenditure worldwide

RESTRAINTS

Stringent regulatory procedures regarding approval of drugs and medical devices

Growing concerns regarding antibiotic resistance

INDUSTRY UPDATE

On June 25, 2019, Abbvie Inc. “the company” announced that it has entered into a definitive agreement with Allergan regarding its acquisition. The company will acquire Allergan in a cash transaction of USD 63 billion (approximately).

Pfizer, Inc., in its 2017-18 annual report announced that the company continues to lead the antibiotic industry and comprises of having the widest product portfolio for anti-infectives. In addition, the company is making certain strategic investments for the development of new therapies in the future.

Major industry players profiled as part of the report are GlaxoSmithKline plc., Pfizer Inc., Novartis Pharmaceuticals Corporation, AbbVie Inc., Gilead Sciences, Inc., F. Hoffmann-La Roche Ltd., MELINTA THERAPEUTICS, INC., Cipla Inc., Sun Pharmaceutical Industries Ltd., and Dr. Reddy’s Laboratories Ltd.

Segmentation

The global antibiotic market has been analyzed through following segments:

By Type

Penicillins

Cephalosporins

Macrolides

Others

 

By Geography

North America

USA

Canada

Mexico

 

South America

Brazil

Argentina

Others

 

Europe

Germany

France

United Kingdom

Spain

Others

 

Middle East and Africa

Saudi Arabia

Israel

Others

 

Asia Pacific

China

Japan

South Korea

India

Others

 

Key insights offered

What will be the global antibiotic market size from 2018 to 2024?

How are the major drivers and restraints affecting the global antibiotic market growth and the opportunities which exist for key vendors?

Which segment and region will drive or lead the market growth and why?

A comprehensive analysis of competitive landscape and key market participants’ behaviour

Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth.

OUR CLIENTS